Antibiotic treatment for brucellosis with spine or joint infection
Part of Bones, joints & muscles, Infections clinical trials.
This trial tests a type of antibiotic called fluoroquinolones to treat brucellosis, a bacterial infection that can cause fever, joint pain, and other symptoms. It focuses on people who also have infection in the spine or the sacroiliac joint (where the spine meets the pelvis). The goal is to see if this treatment is safe and works well for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with brucellosis, confirmed by a positive blood test or culture.
- You have symptoms like fever, sweating, joint pain, headache, or tiredness.
- You also have infection in the spine or the sacroiliac joint (where the spine meets the pelvis).
- You have not taken certain medications (like steroids or anti-tuberculosis drugs) in the past 3 months.
- You are not pregnant, breastfeeding, or planning to become pregnant soon.
- You do not have other serious conditions like tuberculosis, advanced cancer, or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with confirmed brucellosis, epidemic hemorrhagic fever, or kala-azar (visceral leishmaniasis) to understand how these infections behave in real life. It may help improve care by collecting evidence on diagnosis and treatment outcomes.
This study tests whether adding the antibiotic rifampicin to standard treatment works better than standard treatment alone for staph infections in hip or knee replacements. The goal is to find a more effective way to clear the infection and avoid more surgeries.
This trial tests whether adding the antibiotic doxycycline to standard treatment can improve recovery in patients with tuberculosis of the brain (TB meningitis). It may help reduce brain swelling and damage.
This trial tests whether adding a common antibiotic (benzathine penicillin) to a standard biologic drug (etanercept) can better treat spondyloarthritis. It may help if you have active disease and are free of certain infections.
This trial tests whether adding corticosteroids (a type of steroid that reduces inflammation) to standard antibiotic treatment can improve recovery from septic arthritis—a serious joint infection. It aims to see if this combination can reduce pain and improve joint function.
This trial compares taking antibiotics by mouth versus through an IV line for people who have an infection in their hip or knee replacement. The goal is to see if oral antibiotics work just as well as IV antibiotics after surgery to clean the infection.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.